Weather delay for achondroplasia meeting

FDA postponed until further notice the March 22 joint meeting of the Pediatric Advisory Committee (PAC) and Endocrinologic and Metabolic Drugs Advisory Committee (EMDAC) due to inclement weather.

The committees are slated to discuss drug development for pediatric patients with achondroplasia (ACH), including appropriate study design and endpoints...